Gelonghui February 20 丨Huadong Pharmaceutical (000963.SZ) was surveyed on-site by the agency at 14:30-16:00 on February 15, 2023; 11:00-11:40 and 14:00-15:00 on February 16, saying that Maggie Health has already accumulated a number of intended customers and orders, which will lay a good foundation for development after it is officially put into operation in the second half of this year. Huaren Technology's main business areas are small nucleic acid drugs and nucleoside raw materials for diagnostic reagents. As the global epidemic situation slows down, the growth rate of the diagnostic reagent business will decline compared to before. However, the field of nucleoside raw materials for small nucleic acid drugs still has great potential and room for expansion. Huaren Technology also has a rich product library. In the future, it will accelerate the industrialization of this type of business and continue to expand the international market with the help of the company's internationalization capabilities. This year, we will aim for a faster growth rate compared to last year as a whole, and continuously enhance the market competitiveness of the company's industrial microbial nucleoside business.